Cargando…
Patient-derived three-dimensional cortical neurospheres to model Parkinson’s disease
There are currently no preventive or disease-modifying therapies for Parkinson’s Disease (PD). Failures in clinical trials necessitate a re-evaluation of existing pre-clinical models in order to adopt systems that better recapitulate underlying disease mechanisms and better predict clinical outcomes...
Autores principales: | Raja, Waseem K., Neves, Esther, Burke, Christopher, Jiang, Xin, Xu, Ping, Rhodes, Kenneth J., Khurana, Vikram, Scannevin, Robert H., Chung, Chee Yeun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714816/ https://www.ncbi.nlm.nih.gov/pubmed/36454869 http://dx.doi.org/10.1371/journal.pone.0277532 |
Ejemplares similares
-
A Brain-Penetrant Stearoyl-CoA Desaturase Inhibitor Reverses α-Synuclein Toxicity
por: Nuber, Silke, et al.
Publicado: (2022) -
Correction to: A Brain-Penetrant Stearoyl-CoA Desaturase Inhibitor Reverses α-Synuclein Toxicity
por: Nuber, Silke, et al.
Publicado: (2022) -
Human Neurospheres as Three-Dimensional Cellular Systems for Developmental Neurotoxicity Testing
por: Moors, Michaela, et al.
Publicado: (2009) -
Non-clinical Pharmacology of YTX-7739: a Clinical Stage Stearoyl-CoA Desaturase Inhibitor Being Developed for Parkinson’s Disease
por: Tardiff, Daniel F., et al.
Publicado: (2022) -
Characterization of neural stem cells derived from human stem cells from the apical papilla undergoing three-dimensional neurosphere induction
por: SONGSAAD, Anupong Thongklam, et al.
Publicado: (2023)